Lab of Molecular Pathology and Theranostics
제목: IRS2 Amplification as a Predictive Biomarker in Response to Ceritinib in Small Cell Lung Cancer
저널: Molecular Therapy Oncolytics
연권호: 2020 Jan 10;16:188-196. doi: 10.1016/j.omto.2019.12.009.